CL2008003599A1 - Un compuesto 3-[metoxi(fenil)metilen]-2-oxoindolino-6-carboxilato de metilo; y su procedimiento de fabricacion. - Google Patents

Un compuesto 3-[metoxi(fenil)metilen]-2-oxoindolino-6-carboxilato de metilo; y su procedimiento de fabricacion.

Info

Publication number
CL2008003599A1
CL2008003599A1 CL2008003599A CL2008003599A CL2008003599A1 CL 2008003599 A1 CL2008003599 A1 CL 2008003599A1 CL 2008003599 A CL2008003599 A CL 2008003599A CL 2008003599 A CL2008003599 A CL 2008003599A CL 2008003599 A1 CL2008003599 A1 CL 2008003599A1
Authority
CL
Chile
Prior art keywords
compound
oxoindoline
carboxylate
methoxy
methylene
Prior art date
Application number
CL2008003599A
Other languages
English (en)
Inventor
Joern Merten
Carsten Reichel
Svenja Renner
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40718253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008003599(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CL2008003599A1 publication Critical patent/CL2008003599A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)

Abstract

LA PRESENTE INVENCIÓN DESCRIBE A UN COMPUESTOS DE FÓRMULA 2, Y A SU PROCEDIMIENTO DE FABRICACIÓN.
CL2008003599A 2007-12-03 2008-12-02 Un compuesto 3-[metoxi(fenil)metilen]-2-oxoindolino-6-carboxilato de metilo; y su procedimiento de fabricacion. CL2008003599A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07122123 2007-12-03

Publications (1)

Publication Number Publication Date
CL2008003599A1 true CL2008003599A1 (es) 2010-08-20

Family

ID=40718253

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003599A CL2008003599A1 (es) 2007-12-03 2008-12-02 Un compuesto 3-[metoxi(fenil)metilen]-2-oxoindolino-6-carboxilato de metilo; y su procedimiento de fabricacion.

Country Status (36)

Country Link
US (1) US8067617B2 (es)
EP (1) EP2229360B1 (es)
JP (2) JP5933924B2 (es)
KR (2) KR101676261B1 (es)
CN (1) CN101883755B (es)
AR (1) AR069531A1 (es)
AU (1) AU2008333287B2 (es)
BR (1) BRPI0819991B1 (es)
CA (1) CA2705490C (es)
CL (1) CL2008003599A1 (es)
CO (1) CO6210751A2 (es)
CY (1) CY1123333T1 (es)
DK (1) DK2229360T3 (es)
EA (1) EA016196B1 (es)
EC (1) ECSP10010195A (es)
ES (1) ES2818993T3 (es)
HK (1) HK1145682A1 (es)
HR (1) HRP20201480T1 (es)
HU (1) HUE051550T2 (es)
IL (1) IL205348A (es)
LT (1) LT2229360T (es)
MA (1) MA31989B1 (es)
MX (1) MX2010005557A (es)
MY (1) MY148574A (es)
NZ (1) NZ585798A (es)
PE (1) PE20091445A1 (es)
PL (1) PL2229360T3 (es)
PT (1) PT2229360T (es)
RS (1) RS60818B1 (es)
SI (1) SI2229360T1 (es)
TN (1) TN2010000248A1 (es)
TW (1) TWI432415B (es)
UA (1) UA97872C2 (es)
UY (1) UY31506A1 (es)
WO (1) WO2009071524A2 (es)
ZA (1) ZA201002723B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY31506A1 (es) * 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
WO2012068441A2 (en) 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
CN103787949A (zh) * 2012-10-31 2014-05-14 韩冰 一类保护移植器官的化合物及其用途
US20140350022A1 (en) 2013-05-10 2014-11-27 Boehringer Ingelheim International Gmbh Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
CA3172586A1 (en) 2013-07-31 2015-02-05 Avalyn Pharma Inc. Aerosol imatininb compounds and uses thereof
US20140342772A1 (en) * 2013-09-12 2014-11-20 Bandwidth.Com, Inc. Predictive Caching of IP Data
CN104262232B (zh) * 2014-09-09 2016-05-04 苏州明锐医药科技有限公司 尼泰达尼的制备方法
CN105712923A (zh) * 2014-12-03 2016-06-29 江苏先声药业有限公司 一种尼达尼布杂质及其制备方法与应用
WO2016178064A1 (en) 2015-05-06 2016-11-10 Suven Life Sciences Limited Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof
CN105001143A (zh) * 2015-07-24 2015-10-28 南京正大天晴制药有限公司 一种制备高纯度乙磺酸尼达尼布的方法
WO2017077551A2 (en) 2015-11-03 2017-05-11 Mylan Laboratories Limited An amorphous nintedanib esylate and solid dispersion thereof
CN109415314A (zh) * 2016-05-19 2019-03-01 上海诚妙医药科技有限公司 尼达尼布的新晶型及其制备方法及其用途
CN106543069A (zh) * 2016-09-20 2017-03-29 北京万全德众医药生物技术有限公司 6‑甲氧基羰基‑2‑氧代二氢吲哚的制备
CN108610308A (zh) * 2016-12-09 2018-10-02 上海奥博生物医药技术有限公司 一锅法制备尼达尼布中间体的方法
CN106841495B (zh) * 2017-04-21 2018-05-11 常州佳德医药科技有限公司 乙磺酸尼达尼布中基因毒性杂质的高灵敏度分析方法
WO2019048974A1 (en) * 2017-09-06 2019-03-14 Glenmark Pharmaceuticals Limited PROCESS FOR PREPARING NINTEDANIB
CA3082714A1 (en) 2017-11-17 2019-05-23 Fermion Oy Synthesis of a 2-indolinone derivative known as intermediate for preparing nintedanib
CN110746378B (zh) * 2018-12-03 2021-11-05 江苏豪森药业集团有限公司 一种胺基中间体的制备方法
CN111377845A (zh) * 2018-12-27 2020-07-07 江苏先声药业有限公司 3-(二甲氨基(苯基)亚甲基)-2-氧化吲哚-6-羧酸甲酯及其制备方法与应用
CN111662223B (zh) * 2019-03-08 2023-07-14 四川科伦药物研究院有限公司 二氢吲哚酮衍生物及其中间体的制备方法
US20240051920A1 (en) * 2020-08-07 2024-02-15 Bdr Lifesciences Private Limited An improved highly efficient process for the preparation of nintedanib and pharmaceutically acceptable salt thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4876863A (es) * 1972-01-22 1973-10-16
US6469181B1 (en) * 1995-01-30 2002-10-22 Catalytica, Inc. Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
DK1115704T3 (da) 1998-09-25 2003-09-29 Boehringer Ingelheim Pharma Substituerede indolinoner med inhiberende virkning for forskellige kinaser og cyclin/CDK komplekser
US7291641B2 (en) * 1999-10-11 2007-11-06 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
UA75054C2 (uk) * 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
DE10117204A1 (de) * 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE10233500A1 (de) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
WO2008056634A1 (fr) * 2006-11-06 2008-05-15 Theravalues Corporation Nouveau dérivé d'hydroxyindole
UY31506A1 (es) * 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
AR069530A1 (es) * 2007-12-03 2010-01-27 Boehringer Ingelheim Int Procedimiento para la fabricacion de un derivado de indolinona

Also Published As

Publication number Publication date
TWI432415B (zh) 2014-04-01
KR101676261B1 (ko) 2016-11-15
WO2009071524A3 (en) 2009-10-01
JP6044025B2 (ja) 2016-12-14
CO6210751A2 (es) 2010-10-20
EA201000883A1 (ru) 2010-12-30
JP5933924B2 (ja) 2016-06-15
HRP20201480T1 (hr) 2020-12-11
TN2010000248A1 (fr) 2011-11-11
BRPI0819991B1 (pt) 2022-02-15
EA016196B1 (ru) 2012-03-30
ECSP10010195A (es) 2010-07-30
US20100311985A1 (en) 2010-12-09
WO2009071524A2 (en) 2009-06-11
IL205348A0 (en) 2010-12-30
CA2705490C (en) 2016-02-02
BRPI0819991A2 (pt) 2015-05-12
DK2229360T3 (da) 2020-09-28
MA31989B1 (fr) 2011-01-03
PL2229360T3 (pl) 2020-12-14
UA97872C2 (ru) 2012-03-26
KR20100097129A (ko) 2010-09-02
RS60818B1 (sr) 2020-10-30
HK1145682A1 (en) 2011-04-29
CA2705490A1 (en) 2009-06-11
AU2008333287A1 (en) 2009-06-11
KR101712810B1 (ko) 2017-03-07
ZA201002723B (en) 2010-12-29
MY148574A (en) 2013-04-30
CN101883755A (zh) 2010-11-10
HUE051550T2 (hu) 2021-03-01
JP2011505346A (ja) 2011-02-24
LT2229360T (lt) 2020-10-12
IL205348A (en) 2014-06-30
AR069531A1 (es) 2010-01-27
KR20150116909A (ko) 2015-10-16
EP2229360B1 (en) 2020-07-01
JP2015071602A (ja) 2015-04-16
EP2229360A2 (en) 2010-09-22
CY1123333T1 (el) 2021-12-31
ES2818993T3 (es) 2021-04-14
CN101883755B (zh) 2013-06-26
MX2010005557A (es) 2010-06-01
TW200930702A (en) 2009-07-16
US8067617B2 (en) 2011-11-29
NZ585798A (en) 2011-06-30
SI2229360T1 (sl) 2020-11-30
UY31506A1 (es) 2009-08-03
AU2008333287B2 (en) 2013-12-19
PT2229360T (pt) 2020-09-15
PE20091445A1 (es) 2009-10-19

Similar Documents

Publication Publication Date Title
CL2008003599A1 (es) Un compuesto 3-[metoxi(fenil)metilen]-2-oxoindolino-6-carboxilato de metilo; y su procedimiento de fabricacion.
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
GB0521508D0 (en) Organic compounds
DK1907373T3 (da) Fremgangsmåder til fremstillingen af 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindolin-1,3-dionforbindelser
WO2007030582A3 (en) Acyclic ikur inhibitors
BRPI0719626A2 (pt) '' composto ''
CY1112705T1 (el) Συντηγμενες κυκλικες ενωσεις
NL1028948A1 (nl) Ortho gesubstitueerde aryl- of heteroarylamideverbindingen.
WO2008083248A3 (en) Cyclopamine analogs
UA107791C2 (en) Pesticidal compositions
SE0601145L (sv) Vakuumöppningar av höghastighetstyp
CO6220968A2 (es) Inhibidores heterociclicos de la aspartil proteasa
CR10353A (es) Nuevos compuestos.
NL1031385A1 (nl) Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen.
ITBO20050184A1 (it) Apparecchiatura di produzione di filtri composti
NL1031335A1 (nl) Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.
DE602005009127D1 (de) Siliziumverbindung
UY31688A1 (es) Plaguicidas
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
DE602006008072D1 (de) Elastomerverbindung
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
CY1113916T1 (el) Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης
DOP2009000088A (es) Pirazoles sustituidos que presentan actividad anticancerígena